BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2018
View Archived Issues
Chemical changes make arylomycins great against Gram-negatives
Read More
Zinc fingers go where CRISPR can't
Read More
Viva VIVO
Read More
White matter targeting improves TBI outcomes
Read More
Iterum announces the initiation of SURE 2 and SURE 3 phase III studies for sulopenem
Read More
Identification of a diagnostic gene signature in Kawasaki disease
Read More
Mechanisms of bacterial competition used by microbiota as a tool to develop new targeted antibiotics
Read More
Molecular Templates and Takeda enter agreement for joint development of CD38-targeted ETBs
Read More
Servier to use Poietis' 4D bioprinting technology for liver tissue
Read More
China Pharmaceutical University, Hefei Yigong Medicine describe new colchicine derivatives
Read More
Beijing Scitech-Mq Pharmaceuticals patents VEGFR-2 and HGFR inhibitors
Read More
Fujian Cosunter Pharmaceutical, Medshine Discovery divulge compounds for HBV infection
Read More
Neuronascent receives award to further develop NNI-362 for Alzheimer's
Read More
Apeiron Biologics and Lead Discovery Center to develop novel immune checkpoint modulators
Read More
Researchers present data for GSK-773 in myopathy
Read More
Preclinical profile of PI3K-delta inhibitor DS-1515 shows potential for treating asthma
Read More
Erytech begins phase III trial of eryaspase in second-line metastatic pancreatic cancer
Read More
Amygdala Neurosciences announces SEARCH phase II studies with ANS-6637
Read More
Oxurion initiates phase II study of THR-317 in macular telangiectasia type 1
Read More
Nanobiotix reports new data on NBTXR-3
Read More
Celltrion signs incubation agreement with Emory University to support atherosclerosis R&D
Read More
TAS-303 shows potential as a novel therapeutic agent for stress urinary incontinence
Read More
Mutations in ADPRHL2 linked to a degenerative pediatric stress-induced epileptic ataxia syndrome
Read More
RNF146 identified as novel therapeutic target in colorectal cancer
Read More
Immune system activation observed in phase I trial of AST-008
Read More